emendrix

Art. 6

Classification, Labelling and Packaging Regulation · 32008R1272 · every event for this act · on EUR-Lex

Identification and examination of available information on mixtures

3 changes recorded across 3 events, newest first.

in force 2026-07-01 MODIFIED+811 −171

Amended by Regulation (EU) 2024/2865 32024R2865

applies from: unchanged

A new point (ca) was added to paragraph 1 listing data obtained from new approach methodologies as a type of information to be identified.

Paragraph 3 now also covers endocrine disruption for human health and for the environment among the hazard classes for which only substance-level information is used, adds references to sections 3.11.3.1 and 4.2.3.1 of Annex I, states explicitly that this information is used for the substances and not for the mixture itself, and extends the rule on mixture test data showing unidentified effects to also cover endocrine disruption effects.

Paragraph 4 now also covers persistency and mobility properties, PBT/vPvB and PMT/vPvM hazard classes with added Annex I section references, and likewise states that substance-level information is used and not information on the mixture itself.

Cited: Art. 6, v2 · Art. 6, v1

text before / after

02008R1272-2026050102008R1272-20260701

Article 6 Identification and examination of available information on mixtures 1. Manufacturers, importers and downstream users of a mixture shall identify the relevant available information on the mixture itself or the substances contained in it for the purposes of determining whether the mixture entails a physical, health or environmental hazard as set out in Annex I, and, in particular, the following: (a) data generated in accordance with any of the methods referred to in Article 8(3) on the mixture itself or the substances contained in it; (b) epidemiological data and experience on the effects on humans for the mixture itself or the substances contained in it, such as occupational data or data from accident databases; (c) any other information generated in accordance with section 1 of Annex XI to Regulation (EC) No 1907/2006 for the mixture itself or the substances contained in it; (ca) data obtained from new approach methodologies; (d) any other information generated under internationally recognised chemical programmes for the mixture itself or the substances contained in it. The information shall relate to the forms or physical states in which the mixture is placed on the market and, when relevant, in which it can reasonably be expected to be used. 2. Subject to paragraphs 3 and 4, where the information referred to in paragraph 1 is available for the mixture itself, and the manufacturer, importer or downstream user has ascertained that information to be adequate and reliable and where applicable, scientifically valid, that manufacturer, importer or downstream user shall use that information for the purposes of the evaluation pursuant to Chapter 2 of this Title. 3. For the evaluation of mixtures pursuant to Chapter chapter 2 of this Title in relation to the germ cell mutagenicity, carcinogenicity carcinogenicity, reproductive toxicity, endocrine disruption for human health and reproductive toxicity endocrine disruption for the environment hazard classes referred to in sections 3.5.3.1, 3.6.3.1 3.6.3.1, 3.7.3.1, 3.11.3.1 and 3.7.3.1 4.2.3.1 of Annex I, the manufacturer, importer or and downstream user shall only use the relevant available information referred to in paragraph 1 for the substances in the mixture. Further, in cases where mixture and not for the mixture itself. Where the available test data on the mixture itself demonstrate germ cell mutagenic, carcinogenic or toxic to reproduction effects properties, or endocrine disruption for human health or the environment which have not been identified from the relevant available information on the individual substances, substance referred to in the first subparagraph, those data shall also be taken into account. account for the purposes of the evaluation of the mixture referred to in the first subparagraph. 4. For the evaluation of mixtures pursuant to Chapter 2 of this Title in relation to the biodegradation biodegradation, persistency, mobility and bioaccumulation properties within the hazardous to the aquatic environment environment, persistent, bioaccumulative and toxic or very persistent, very bioaccumulative properties and persistent, mobile and toxic or very persistent, very mobile properties hazard class classes referred to in sections 4.1.2.8 4.1.2.8, 4.1.2.9, 4.3.2.3.1, 4.3.2.3.2, 4.4.2.3.1 and 4.1.2.9 4.4.2.3.2 of Annex I, the manufacturer, importer or and downstream user shall only use the relevant available information referred to in paragraph 1 for the substances in the mixture. mixture and not for the mixture itself. 5. Where no or inadequate test data on the mixture itself of the kind referred to in paragraph 1 are available, the manufacturer, importer or downstream user shall use other available information on individual substances and similar tested mixtures which may also be considered relevant for the purposes of determining whether the mixture is hazardous, provided that that manufacturer, importer or downstream user has ascertained that information to be adequate and reliable for the purpose of the evaluation pursuant to Article 9(4).

in force 2025-02-01 MODIFIED

Amended by Regulation (EU) 2023/1435 32023R1435

applies from: unchanged

Sources disagree — the text comparison found this change; the EU's own amendment metadata does not list it and the amending act's instructions do not mention it. All are shown; none is overruled.

Paragraph 3 no longer refers to endocrine disruption for human health or the environment, nor to the corresponding sections 3.11.3.1 and 4.2.3.1 of Annex I, and now covers only germ cell mutagenicity, carcinogenicity and reproductive toxicity under sections 3.5.3.1, 3.6.3.1 and 3.7.3.1.

The second subparagraph of paragraph 3 drops the reference to endocrine disruption effects and to the individual substance being addressed under the first subparagraph, referring instead only to germ cell mutagenic, carcinogenic or toxic to reproduction effects not identified from information on individual substances.

Paragraph 4 removes the references to mobility, persistent bioaccumulative and toxic, very persistent very bioaccumulative, and persistent mobile and toxic or very persistent very mobile properties along with sections 4.3.2.3.1, 4.3.2.3.2, 4.4.2.3.1 and 4.4.2.3.2, leaving only biodegradation and bioaccumulation under sections 4.1.2.8 and 4.1.2.9.

Cited: Art. 6, v1 · Art. 6, v2

text before / after, on the event page →

in force 2024-12-10 MODIFIED

Amended by Regulation (EU) 2024/2865 32024R2865

applies from: unchanged

Sources disagree — the text comparison and the amending act's instructions found this change; the EU's own amendment metadata does not list it. All are shown; none is overruled.

Paragraph 3 now lists endocrine disruption for human health and endocrine disruption for the environment alongside germ cell mutagenicity, carcinogenicity and reproductive toxicity, adding references to sections 3.11.3.1 and 4.2.3.1 of Annex I, and it now states that the substance-based information is to be used and not the information on the mixture itself, with the second subparagraph correspondingly extended to cover endocrine disruption effects.

Paragraph 4 adds persistency and mobility to the biodegradation and bioaccumulation properties covered, adds references to sections 4.3.2.3.1, 4.3.2.3.2, 4.4.2.3.1 and 4.4.2.3.2 of Annex I alongside the existing 4.1.2.8 and 4.1.2.9, and now also states that only substance information is to be used and not the mixture's own information.

Cited: Art. 6, v1 · Art. 6, v2

text before / after, on the event page →